Matches in Nanopublications for { ?s ?p ?o <http://www.tkuhn.ch/bel2nanopub/RAkrBGARCL_Z8Qd7rsHlJHLv-eN-yGr5nHyh4pK1Mz64E#provenance>. }
Showing items 1 to 11 of
11
with 100 items per page.
- _3 label "Selventa" provenance.
- large_corpus.bel title "BEL Framework Large Corpus Document" provenance.
- large_corpus.bel description "Approximately 61,000 statements." provenance.
- large_corpus.bel version "20131211" provenance.
- large_corpus.bel authoredBy _3 provenance.
- assertion wasDerivedFrom large_corpus.bel provenance.
- assertion wasDerivedFrom _2 provenance.
- assertion hadPrimarySource 18483355 provenance.
- _2 wasQuotedFrom 18483355 provenance.
- _2 value "Epidermal growth factor receptor (EGFR)–specific tyrosine kinase inhibitors (TKI) gefitinib and erlotinib have been developed as therapeutic agents for non–small cell lung cancer (NSCLC) treatment (1, 2, 3)." provenance.
- large_corpus.bel rights "Copyright (c) 2011-2012, Selventa. All rights reserved." provenance.